Otsuka Holdings Co., Ltd. (4578.T)

Tokyo · Healthcare · Drug Manufacturers - General
12,390.00 JPY+1.93%As of 2026-11-22 · JPY
Last session low 11,910.00 JPYLast session high 12,455.00 JPY
52-week low 8,545.00 JPY52-week high 12,795.00 JPY
Market cap (USD)
$40.93B
Sector
Healthcare
P/E (TTM)
16.9x
Dividend yield
1.61%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-19 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in JPY.

IndicatorValueReading
RSI (14)51.3In the neutral range (30 to 70)
MACD (12, 26, 9)100.17Below its signal line (100.58); histogram -0.41
Bollinger %B (20, 2)71%Inside the bands (11,685.11 to 12,680.39)
SMA 2012,182.75Price is 1.7% above
SMA 5011,821.80Price is 4.8% above
SMA 20011,130.79Price is 11.3% above
ATR (20)2.84% of priceAverage true range per day
52-week position90%In the upper part of the 8,545.00 to 12,795.00 range

About Otsuka Holdings Co., Ltd.

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices.

Latest fiscal yearEnded 2025-12-31: revenue of 2.47T JPY and an operating margin of 19.1%.

More in Drug Manufacturers - General